XML 55 R43.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 1 - Organization and Nature of Business (Details Textual)
2 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 27, 2016
$ / shares
shares
Jun. 27, 2016
$ / shares
shares
Apr. 16, 2016
USD ($)
Apr. 15, 2016
USD ($)
$ / shares
shares
Mar. 02, 2016
USD ($)
shares
Feb. 13, 2016
Feb. 12, 2016
USD ($)
$ / shares
shares
Apr. 15, 2016
USD ($)
$ / shares
shares
Jun. 30, 2016
$ / shares
shares
Apr. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
$ / shares
shares
Jun. 30, 2015
USD ($)
Dec. 31, 2015
$ / shares
shares
Dec. 31, 2014
$ / shares
shares
Jun. 26, 2016
$ / shares
shares
Oct. 02, 2015
$ / shares
shares
Oct. 01, 2015
shares
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member] | New Options [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             1,807,744                    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares             $ 0.87                    
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member] | New Warrants [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             3,403,367                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares             $ 1.03                    
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member] | Predecessor Options [Member]                                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             17,784                    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares             $ 1.25                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             295,945                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares             $ 1.25                    
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member]                                  
Common Shares Exchanged for Preferred Shares             (6,612,838)                    
Preferred Stock, Par or Stated Value Per Share | $ / shares             $ 0.000001                    
Protagenic Therapeutics Inc [Member] | Private Placement [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             3,403,367                    
Protagenic Therapeutics Inc [Member] | Placement Agent Warrants [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             127,346                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares             $ 1.25                    
Protagenic Therapeutics Inc [Member] | Predecessor Warrants [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             295,945                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares             $ 1.25                    
Protagenic Therapeutics Inc [Member]                                  
Business Acquisition, Conversion of Stock, Ratio             1                    
Business Combination, Stock Warrant Conversion Ratio             1                    
Stock Issued During Period, Shares, Conversion of Series A Preferred Stock to Series B Preferred Stock             297,468                    
Series B Preferred Stock [Member] | Private Placement [Member] | Placement Agent Warrants [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       127,346       127,346                  
Class of Warrant or Right, Value of Securities Called by Warrants or Rights | $       $ 146,641       $ 146,641                  
Series B Preferred Stock [Member] | Private Placement [Member] | Including Conversion of Principal and Interest [Member] | Subsequent Event [Member]                                  
Proceeds from Issuance of Private Placement | $                   $ 4,635,575              
Proceeds From Issuance of Private Placement, Net of Issuance Costs | $                   $ 4,283,438              
Series B Preferred Stock [Member] | Private Placement [Member] | Including Conversion of Principal and Interest [Member]                                  
Proceeds from Issuance of Private Placement | $               5,135,575                  
Proceeds From Issuance of Private Placement, Net of Issuance Costs | $               $ 4,783,438                  
Series B Preferred Stock [Member] | Private Placement [Member] | Subsequent Event [Member]                                  
Stock Issued During Period, Shares, New Issues       420,260                          
Series B Preferred Stock [Member] | Private Placement [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             423,291                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares             $ 1.25                    
Shares Issued, Price Per Share | $ / shares             $ 1.25                    
Stock Issued During Period, Value, New Issues | $             $ 3,468,750                    
Stock Issued During Period, Shares, New Issues       420,260 913,200   2,775,000 4,108,460                  
Proceeds from Issuance of Convertible Preferred Stock | $       $ 525,325 $ 1,141,500                        
Proceeds from Issuance of Private Placement | $               $ 4,635,575                  
Proceeds From Issuance of Private Placement, Net of Issuance Costs | $               $ 4,283,438                  
Series B Preferred Stock [Member] | Predecessor Warrants [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             295,945                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares             $ 1.25                    
Warrants Issued for Settlement and Conversion of Debt | $             $ 340,784                    
Series B Preferred Stock [Member] | Reverse Stock Split [Member] | Subsequent Event [Member]                                  
Stockholders' Equity Note, Stock Split, Conversion Ratio 15,463.7183                                
Series B Preferred Stock [Member] | Reverse Stock Split [Member]                                  
Stockholders' Equity Note, Stock Split, Conversion Ratio             15,463.7183                    
Series B Preferred Stock [Member] | Subsequent Event [Member]                                  
Proceeds from Issuance of Private Placement | $       525,325                          
Series B Preferred Stock [Member]                                  
Preferred Stock, Par or Stated Value Per Share | $ / shares                 $ 0.000001   $ 0.000001   $ 0.000001        
Proceeds from Issuance of Convertible Preferred Stock | $                     $ 4,283,437          
Preferred Stock, Shares Authorized                 18,000,000   18,000,000   18,000,000        
Common Stock [Member]                                  
Stock Issued During Period, Shares, Reverse Stock Split, Post-split             25,867                    
Stock Issued During Period, Value, New Issues | $                                
Stock Issued During Period, Value, Conversion of Convertible Securities | $                     $ 6            
Stock Issued During Period, Shares, New Issues                       0 0      
Debt Principal Conversion to Predecessor Warrants [Member]                                  
Debt Conversion, Original Debt, Amount | $             $ 665,000                    
Debt Interest Conversion to Predecessor Warrants [Member]                                  
Debt Conversion, Original Debt, Amount | $             35,000                    
Conversion of Outstanding Stockholder Debt [Member] | Predecessor's Stockholder [Member]                                  
Stock Issued During Period, Value, Conversion of Convertible Securities | $             150,000                    
Conversion of Outstanding Stockholder Debt [Member] | Chairman and Board Member Garo H. Armen [Member]                                  
Stock Issued During Period, Value, Conversion of Convertible Securities | $             $ 350,000                    
Momspot LLC [Member]                                  
Noncontrolling Interest, Ownership Percentage by Parent             51.00%                    
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners             49.00%                    
Interest Ownership Split Off           51.00%                      
Investors in the Private Offering [Member]                                  
Number of Common Stock Held As Converted Basis             2,775,000                    
Private Placement [Member] | Commissions [Member]                                  
Payments of Stock Issuance Costs | $       159,183                          
Private Placement [Member] | Expense Allowance [Member]                                  
Payments of Stock Issuance Costs | $       15,000                          
Private Placement [Member] | Legal and Miscellaneous Fees [Member]                                  
Payments of Stock Issuance Costs | $       $ 266,727                          
Private Placement [Member] | Placement Agent Warrants [Member]                                  
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       $ 1.25       $ 1.25                  
Private Placement [Member] | Subsequent Event [Member]                                  
Proceeds from Issuance of Private Placement | $     $ 4,635,575                            
Proceeds From Issuance of Private Placement, Net of Issuance Costs | $     $ 4,283,438                            
Reverse Stock Split [Member]                                  
Stockholders' Equity Note, Stock Split, Conversion Ratio   15,463.7183                              
Subsequent Event [Member] | Stock Conversion from Series B Preferred Stock to Common Stock [Member]                                  
Convertible Preferred Stock, Shares Issued upon Conversion 1                                
Conversion of Stock, Shares Converted 11,018,766                                
Conversion of Stock, Shares Issued 11,018,766                                
Subsequent Event [Member]                                  
Preferred Stock, Par or Stated Value Per Share | $ / shares $ 0.000001                                
Common Stock, Par or Stated Value Per Share | $ / shares $ 0.0001                                
Stock Shares Authorized 120,000,000                                
Common Stock, Shares Authorized 100,000,000                                
Preferred Stock, Shares Authorized 20,000,000                                
Stock Conversion from Series B Preferred Stock to Common Stock [Member]                                  
Convertible Preferred Stock, Shares Issued upon Conversion   1                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                     1,301,084   490,000 240,000      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares                 $ 1.25   $ 1.25   $ 1.25 $ 1      
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares                         1        
Common Stock, Par or Stated Value Per Share | $ / shares   $ 0.0001         $ 0.0001   $ 0.0001   $ 0.0001   $ 0.0001 $ 0.001 $ 0.000001 $ 0.001  
Number of Wholly-Owned Subsidiaries Split Off           29                      
Stock Issued During Period, Value, New Issues | $                     $ 4,761,797            
Stock Issued During Period, Value, Conversion of Convertible Securities | $                     75,265            
Warrants Issued for Settlement and Conversion of Debt | $                     $ 340,784          
Conversion of Stock, Shares Converted 11,018,766                                
Common Stock, Shares Authorized   100,000,000             100,000,000   100,000,000   20,000,000 20,000,000 100,000,000,000 20,000,000 10,000,000
Preferred Stock, Shares Authorized   20,000,000                         5,000,000,000